Tirzepatide and alcohol: can you drink on it?

What the label says about alcohol

The Zepbound prescribing information (revised August 2026) doesn't name alcohol as an interaction or tell you to avoid it. MedlinePlus doesn't either. But several of tirzepatide's side effects and warnings overlap with what alcohol does, so drinking deserves some care.

Why drinking on tirzepatide can be a problem

• Worse stomach side effects. Nausea, vomiting and diarrhea are tirzepatide's most common side effects. A 2025 joint advisory from four nutrition and obesity medicine groups says alcohol can worsen nausea and reflux on GLP-1 medicines and recommends keeping it minimal.
• Dehydration and kidneys. Alcohol dehydrates you. The label warns that fluid loss from vomiting or diarrhea can lead to acute kidney injury.
• Low blood sugar. The tirzepatide label warns of low blood sugar, including severe episodes, when it's combined with insulin or a sulfonylurea. The NIH alcohol institute warns that alcohol with diabetes medicines such as glipizide or glyburide can also cause abnormally low blood sugar.
• Pancreatitis. Heavy drinking over years is a known cause of pancreatitis, behind roughly 17% to 25% of U.S. cases. Pancreatitis is a warning on the tirzepatide label.
• Low blood pressure and dizziness. In trials, low blood pressure was more common on Zepbound than placebo and was linked with stomach side effects and dehydration.

Get medical care right away for stomach pain that won't go away, with or without vomiting, especially if it spreads to your back. If you take insulin or a sulfonylurea, treat shakiness, sweating, confusion, dizziness or a fast heartbeat as possible low blood sugar.

A small 2025 trial found semaglutide, a related GLP-1 medicine, reduced some drinking measures; see semaglutide and alcohol. Tirzepatide isn't FDA-approved for reducing drinking.

Pregnancy, birth control and breastfeeding

• Pregnancy: the label says weight loss offers no benefit during pregnancy and tirzepatide may cause fetal harm. Stop it when pregnancy is recognized and call your clinician. Unlike the Wegovy label, the Zepbound label doesn't set a specific stop-before-pregnancy window, so plan the timing with your clinician.
• Birth control pills: tirzepatide slows stomach emptying, which can make oral contraceptives less effective. The label advises switching to a non-oral method, or adding a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase.
• Breastfeeding: in a small study of 11 breastfeeding women given one dose, tirzepatide was undetectable or low in breast milk. There are no data on effects on the baby or on milk supply, so you and your clinician weigh the benefits and risks.

Lilly runs a pregnancy registry for people exposed to Zepbound during pregnancy. Your clinician can help you join. Never stop, restart or change your dose on your own. Your clinician decides the dose.

If you choose to drink

• Keep it to small amounts, and have food with it.
• Drink water alongside, especially in the first weeks and after a dose increase, when stomach side effects are most common.
• Skip alcohol on days you have nausea, vomiting or diarrhea.
• Tell your clinician how much you drink. It helps them judge your pancreatitis and low blood sugar risk.

More in what to eat on a GLP-1 and tirzepatide side effects. Through Gabriel, a licensed clinician reviews every prescription request.